OR WAIT null SECS
February 01, 2017
Andrea Zobel, senior director of product management, clinical trial supply, and logistics at PAREXEL International, examines key issues and questions that sponsors and contract partners must address.
Many pharmaceutical manufacturers were late in involving contract partners in serialization efforts. Are you ready, and are you working with the right partner?
As the date for implementation of the Drug Supply Chain Security Act approaches, bio/pharma companies and contractors should focus on key areas.
January 25, 2017
Vetter expanded visual inspection facilities and controlled-temperature storage at its Ravensburg Vetter West facility in Germany.
December 21, 2016
The company has manufactured double-digit number of batches on the new filling line, for use in early-stage clinical trials.
November 17, 2016
The company expanded its commercial packaging facility in response to a growing demand for pediatric drugs.
October 02, 2016
This key bioprocessing segment is expecting continued growth
August 01, 2016
Now past the “wait-and-see” standoff, most pharmaceutical companies and their contract partners are considering long-term requirements, including distributors’ needs.
July 01, 2016
Recipharm adds hardware, software, and cloud services for serialization compliance processes.
August 01, 2015
Sponsors and contract partners alike should not assume that upcoming US federal deadlines will be as elastic as California’s were.